Severe atopic dermatitis and dupilumab

Rev Assoc Med Bras (1992). 2023 Feb 17;69(1):2-6. doi: 10.1590/1806-9282.023D691. eCollection 2023.
No abstract available

MeSH terms

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Dermatitis, Atopic*
  • Humans
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal